biotech investment

R&D

Brighter times ahead for biotech in 2024?

The biotech industry experienced heady highs in early 2021, but has since suffered from a tight financial climate that has brought bankruptcies and widespread redundancies.

R&D

Investing in the gleams of positivity and hope for life scie...

In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at Brit

Digital

An investor’s perspective on bio and tech

Increasingly, the life sciences world is characterised by the collision of the worlds of technology and biology.

Brighter times ahead for biotech in 2024?

Investing in the gleams of positivity and hope for life scie...

An investor’s perspective on bio and tech

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks